Literature DB >> 10590079

DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks.

M B Hemker1, P C Ligthart, L Berger, D J van Rhenen, C E van der Schoot, P A Wijk.   

Abstract

The highly polymorphic Rh system is encoded by 2 homologous genes RHD and RHCE. Gene rearrangements, deletions, or point mutations may cause partial D and CE antigens. In this study, a new RHD variant, DAR, and a new RHCE variant, ceAR, are described in 4 Dutch African Blacks. Serologically, DAR showed weaker reactions with a monoclonal antibody and polyclonal antiserum against D. The DAR phenotype was characterized by complete loss of at least 9 of 37 Rh D epitopes. Erythrocytes expressing ceAR were all typed as VS(-), V(+). DNA analysis showed a partial D allele with only 3 mutations: C602G (exon 4), T667G (exon 5), and T1025C (exon 7). The ceAR allele carried G48C (exon 1), a hybrid exon 5 (A712G, C733G, A787G, and T800A), and A916G (exon 6). To study the frequency of these variants, 326 South-African Blacks was screened genomically. Of the 326 donors, 16 (4.9%) carried the DAR allele, 20 (6.1%) the ceAR allele, and 14 (4.3%) both mutated alleles. Five of these donors (1.5%) had the DAR phenotype, indicating that they carried the DAR allele homozygously or next to a D-negative allele. Immunogenicity of the D antigen for individuals with the DAR phenotype was proven, because 1 of the 4 Dutch individuals produced allo-antibodies against D after multiple transfusions with D-positive blood. In a multiethnic society, the prevalence of this D phenotype will increase and is therefore relevant in transfusion practice and in prevention of hemolytic disease of the newborn.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590079

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  Insights into RHCE Molecular Analysis in Samples with Partial D Variants: the Experience of Western France.

Authors:  Yann Fichou; Cédric Le Maréchal; Virginie Scotet; Déborah Jamet; Claude Férec
Journal:  Transfus Med Hemother       Date:  2015-07-23       Impact factor: 3.747

3.  Weak D in the Tunisian population.

Authors:  Mouna Ouchari; Houda Romdhane; Taher Chakroun; Saida Abdelkefi; Batoul Houissa; Slama Hmida; Saloua Jemni Yacoub
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

Review 4.  Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.

Authors:  S Gerald Sandler; Leonard N Chen; Willy A Flegel
Journal:  Br J Haematol       Date:  2017-05-16       Impact factor: 6.998

5.  RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen.

Authors:  Thamy C Souza Silva; Bruno R Cruz; Sidneia S Costa; Akemi K Chiba; Melca M O Barros; Dante M Langhi; José O Bordin
Journal:  Blood Transfus       Date:  2020-07       Impact factor: 3.443

6.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

7.  DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter-Hipsky; Trina Whorley; Kim Hue-Roye; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2010-01-15       Impact factor: 3.157

Review 8.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

9.  RHCE*ceMO is frequently in cis to RHD*DAU0 and encodes a hr(S) -, hr(B) -, RH:-61 phenotype in black persons: clinical significance.

Authors:  Connie M Westhoff; Sunitha Vege; Trina Horn; Kim Hue-Roye; Christine Halter Hipsky; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2013-06-17       Impact factor: 3.157

10.  Systematic RH genotyping and variant identification in French donors of African origin.

Authors:  Sandrine Kappler-Gratias; Carine Auxerre; Isabelle Dubeaux; Marylise Beolet; Maryline Ripaux; Pierre-Yves Le Pennec; Bach-Nga Pham
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.